Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10920
Title: High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer.
Austin Authors: Azad, Arun A;Chionh, Fiona;Scott, Andrew M ;Lee, Szeting T;Berlangieri, Salvatore U ;White, Shane C;Mitchell, Paul L R 
Affiliation: Ludwig Institute Oncology Unit, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 17-Nov-2009
Publication information: Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging 2009; 12(4): 443-51
Abstract: We evaluated whether 18F-FDG-PET altered stage classification, management, and prognostic stratification of newly diagnosed small cell lung cancer (SCLC).We identified 46 consecutive patients undergoing staging positron emission tomography for SCLC from 1993-2008 inclusive. Updated survival data from the state Cancer Registry was available on 42 of 46 patients.PET altered stage classification in 12 of 46 (26%) patients. PET altered treatment modality in nine patients, and the target mediastinal radiation field in another three patients. Therefore, PET altered management in 12 of 46 (26%) patients. Patients with limited disease (LD) on pre-PET staging had significantly longer overall survival (OS) than those upstaged to extensive disease (ED; median 18.6 months versus 5.7 months; log-rank p < 0.0001). In patients with ED on pre-PET staging, those downstaged to LD by PET had significantly longer OS than those with ED on PET (median 10.9 months versus 5.9 months; log-rank p = 0.037).PET had a major impact on stage classification, management, and prognostic stratification of newly diagnosed SCLC.
Gov't Doc #: 19921339
URI: https://ahro.austin.org.au/austinjspui/handle/1/10920
DOI: 10.1007/s11307-009-0295-z
Journal: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
URL: https://pubmed.ncbi.nlm.nih.gov/19921339
Type: Journal Article
Subjects: Aged
Female
Fluorodeoxyglucose F18.diagnostic use
Humans
Kaplan-Meier Estimate
Lung Neoplasms.pathology.radiography.radionuclide imaging.therapy
Male
Neoplasm Staging
Positron-Emission Tomography
Prognosis
Proportional Hazards Models
Small Cell Lung Carcinoma.pathology.radiography.radionuclide imaging.therapy
Tomography, X-Ray Computed
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
19921339.pdf55.03 kBAdobe PDFView/Open
Show full item record

Page view(s)

24
checked on May 25, 2024

Download(s)

68
checked on May 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.